April 21, 2024


Expect exquisite business

FDA to ‘rapidly work’ towards emergency use authorization for Pfizer-BioNTech vaccine

The Food stuff and Drug Administration mentioned nowadays that pursuing yesterday’s positive advisory committee assembly outcome relating to the Pfizer-BioNTech COVID-19 vaccine, it would promptly do the job toward finalization and issuance of an unexpected emergency use authorization for the COVID-19 vaccine. 

The Fda gave no precise timeline.

The agency has also notified the U.S. Centers for Condition Control and Avoidance and Operation Warp Speed, so they can execute their programs for timely vaccine distribution.

HIMSS20 Digital

Master on-demand, get paid credit rating, locate items and answers. Get Started off >>

Approval implies vaccine distribution would be on Operation Warp Speed’s timetable for distribution to entrance-line healthcare workers and susceptible populations in extended-expression care services by mid-month.

The Fda advisory committee has scheduled another assembly to overview the Moderna vaccine on Thursday, December seventeen.

See our continuing vaccine protection listed here:

Pfizer-BioNTech vaccine will get Fda advisory committee approval

CMS delivers assistance in billing Medicare for COVID-19 antibody procedure

1000’s in the United Kingdom are the very first to receive Pfizer COVID-19 vaccine

Eli Lilly and UnitedHealth Group husband or wife on COVID-19 antibody procedure for significant-hazard individuals

Operation Warp Speed is wanting to begin distributing COVID-19 vaccine by mid-month

Moderna seeks regulatory authorization for its COVID-19 vaccine

HHS will commence allocating Regeneron’s COVID-19 therapeutic this week

HHS partners with chain and impartial pharmacies to improve obtain to future COVID-19 vaccines

COVID-19 vaccine distribution will commence in 24 several hours of an unexpected emergency use authorization

Moderna vaccine candidate shows ninety four.5% efficacy towards COVID-19

Pfizer touts new COVID-19 vaccine, contacting it ‘90% effective’

Medicare beneficiaries can get monoclonal antibody COVID-19 remedies at no expense

Fda grants unexpected emergency use authorization for Eli Lilly antibody procedure for COVID-19

Twitter: @SusanJMorse
Email the author: [email protected]